trending Market Intelligence /marketintelligence/en/news-insights/trending/PTHD9aSktEKWJxIFaYTEDw2 content esgSubNav
In This List

Sagittarius Life Science swings to profit in Q1


Street Talk | Episode 126: Hunting the bears, making the bull case for CRE


Investment Banking Essentials May 15


Panel Discussion: Modernization Initiatives Advancing the U.S. Capital Market


Technology & Automation Insights: Elevating KYC and onboarding efficiency

Sagittarius Life Science swings to profit in Q1

Sagittarius Life Science Corp. said its normalized net income for the first quarter came to 53 Taiwan cents per share, compared with a loss of 24 cents per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was NT$13.7 million, compared with a loss of NT$6.3 million in the prior-year period.

The normalized profit margin climbed to 8.7% from negative 10.4% in the year-earlier period.

Total revenue climbed year over year to NT$157.2 million from NT$59.9 million, and total operating expenses grew 86.1% on an annual basis to NT$133.3 million from NT$71.6 million.

Reported net income came to NT$20.8 million, or 80 cents per share, compared to a loss of NT$10.1 million, or a loss of 39 cents per share, in the year-earlier period.

As of May 15, US$1 was equivalent to NT$30.44.